Deferasirox
id:
deferasirox-184-3430452
title:
Deferasirox
text:
Deferasirox, sold under the brand name Exjade among others, is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias. It is the first oral medication approved in the United States for this purpose. It was approved by the US Food and Drug Administration (FDA) in November 2005.
According to the FDA, kidney failure and cytopenias have been reported in patient
brand slug:
wiki
category slug:
encyclopedia
description:
Oral iron chelator
original url:
https://en.wikipedia.org/wiki/Deferasirox
date created:
2006-03-13T13:22:34Z
date modified:
2024-09-07T04:50:36Z
main entity:
{"identifier":"Q5251502","url":"https://www.wikidata.org/entity/Q5251502"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/3/3b/Deferasirox.svg","width":512,"height":504}
fields total:
13
integrity:
16